chr1-66635959-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032291.4(SGIP1):c.115G>A(p.Glu39Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000124 in 1,613,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032291.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGIP1 | NM_032291.4 | c.115G>A | p.Glu39Lys | missense_variant | 4/25 | ENST00000371037.9 | NP_115667.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SGIP1 | ENST00000371037.9 | c.115G>A | p.Glu39Lys | missense_variant | 4/25 | 1 | NM_032291.4 | ENSP00000360076 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 250840Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135548
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1461578Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 6AN XY: 727060
GnomAD4 genome AF: 0.0000724 AC: 11AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 21, 2023 | The c.115G>A (p.E39K) alteration is located in exon 4 (coding exon 4) of the SGIP1 gene. This alteration results from a G to A substitution at nucleotide position 115, causing the glutamic acid (E) at amino acid position 39 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at